US BioTec, Inc. USBC · Stock Open US BioTec, Inc. in new tab
US BioTec, Inc. Analysis (USBC)
Is US BioTec, Inc. a good investment? US BioTec, Inc. (USBC) is currently trading at 0.4380 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.21. This relatively low multiple may signal that US BioTec, Inc. is undervalued compared to historical market norms.
Investor FAQ
Does US BioTec, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is US BioTec, Inc.?
US BioTec, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
USBC, Inc., together with its subsidiaries, operates in digital financial technologies business in United States. The company develops transformative financial services, including digital assets, banking solutions, and non-invasive health monitoring research. It serves retail users, fintech partners, and institutional counterparties. The company was formerly known as Know Labs, Inc. and changed its name to USBC, Inc. in August 2025. USBC, Inc. was incorporated in 1998 and is based in Reno, Nevada.
| Split Date | Split Ratio to 1 |
|---|---|
| June 17, 2015 | 1:150 |
| Feb. 19, 2025 | 1:40 |
Community Discussion